Mostrando 3 resultados de: 3
Origen
scopus(3)
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
ArticleAbstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a poPalabras claves:Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markersAutores:Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopusEag1 channels as potential cancer biomarkers
ReviewAbstract: Cancer is a leading cause of death worldwide. New early tumor markers are needed to treat the diseasPalabras claves:Cervical Cancer, Colon cancer, estrogens, Ether à-go-go, human papilloma virus, Leukemia, Potassium channels, Prognostic markers, tumor markersAutores:Acuña-Macías I., Javier Camacho, Rodríguez-Rasgado J.A.Fuentes:scopusDifferential regulation of human eagl channel expression by serum and epidermal growth factor in lung and breast cancer cells
ArticleAbstract: Oncogenic ether à-go-go-1 (Eag1) potassium channels are overexpressed in most primary human solid tuPalabras claves:EGF, Epidermal growth factor, ERK 1/2, Ether à-go-go, lung cancer, Potassium channels, Serum deprivationAutores:Acuña-Macías I., Javier Camacho, Mendoza-Garrido M.E., Vázquez-Sánchez A.Y., Vera E.Fuentes:scopus